𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quetiapine augmentation in treatment-resistant depression: a naturalistic study

✍ Scribed by Marina Šagud; Alma Mihaljević-Peleš; Dorotea Mück-Šeler; Miro Jakovljević; Nela Pivac


Publisher
Springer
Year
2006
Tongue
English
Weight
122 KB
Volume
187
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clomipramine augmentation in treatment-r
✍ Jay D. Amsterdam; Felipe García-España; Martin Rosenzweig 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

In depression that is resistant to tricyclic antidepressant (TCA) therapy, the substitution of a selective serotonin re-uptake inhibitor (SSRI), clomipramine, or a monoamine oxidase (MAO) inhibitor has been recommended. However, adding an additional antidepressant medication from a different drug cl

Olanzapine augmentation of milnacipran f
✍ Shuken Boku; Takeshi Inoue; Hiroshi Honma; Shigehiro Matsubara; Shin Nakagawa; T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Objective Olanzapine augmentation of fluoxetine, a selective serotonin reuptake inhibitor, is an effective augmentation therapy for treatment‐resistant depression (TRD). However, studies of olanzapine augmentation of other antidepressants are few. We investigated the efficacy and safety of olanz

Thyroxine Augmentation of Fluoxetine Tre
✍ YORAM BARAK; DANIEL STEIN; JOSEPH LEVINE; ALIZA RING; JACK HADJEZ; AVNER ELIZUR; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Drug resistant depression is a confounding entity. More so in populations of elderly depressives where addition of lithium or antidepressant combinations are possibly hazardous. We present an open-trial of thyroxine in elderly patients diagnosed as suffering from resistant depression. Methods -Thyro